Atlas Trials

Effect of N-Acetylcysteine on Neutrophil Lymphocyte Ratio And Length of Stay In COVID-19 Patients

Clinical trial NCT05658549 · COMPLETED

Trial details

NCT number
NCT05658549
Sponsor
Universitas Sebelas Maret
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
COVID-19
Start date
2021-05-01
Primary completion
2021-07-30
Enrollment
120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.